Aspect Partners’s Helus Pharma HELP Stock Holding History
Bought
Maintained
Sold
Other funds holding HELP
ACA
DA
Aspect Partners's HELP Position: Q3 2026 in Review
Aspect Partners sold out of Helus Pharma (HELP) in Q3 2026, closing a stake of 118 shares — an estimated $780 sold.
Aspect Partners first reported a position in HELP in Q2 2026 and held it in 1 quarter. The position peaked at $780 in Q2 2026. 110 funds tracked by Wall St. Rank hold HELP as of Q3 2026.
- Aspect Partners reported no remaining Helus Pharma position as of Q3 2026 after selling out during the quarter.
- Aspect Partners sold 118 Helus Pharma shares in Q3 2026, an estimated $780.
- Aspect Partners first reported a position in Helus Pharma in Q2 2026 and held it in 1 quarter.
- Aspect Partners's Helus Pharma position peaked at $780 in Q2 2026.
- 110 funds tracked by Wall St. Rank held Helus Pharma as of Q3 2026.
Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.